| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alterations of telomere length and mtDNA copy number are associated with overall survival in hepatocellular carcinoma patients treated with transarterial chemoembolization
|
Bao, Dengke
|
|
2016
|
78 |
4 |
p. 791-799
|
artikel
|
| 2 |
A method for optimizing dosage regimens in oncology by visualizing the safety and efficacy response surface: analysis of inotuzumab ozogamicin
|
Luu, Kenneth T.
|
|
2016
|
78 |
4 |
p. 697-708
|
artikel
|
| 3 |
A phase II study of topotecan and cisplatin with sequential thoracic radiotherapy in elderly patients with small-cell lung cancer: Okayama Lung Cancer Study Group 0102
|
Kubo, Toshio
|
|
2016
|
78 |
4 |
p. 769-774
|
artikel
|
| 4 |
A pilot study of concurrent chemoradiotherapy with gemcitabine and cisplatin in patients with locally advanced biliary tract cancer
|
Lee, Kyong Joo
|
|
2016
|
78 |
4 |
p. 841-846
|
artikel
|
| 5 |
Association of axitinib plasma exposure and genetic polymorphisms of ABC transporters with axitinib-induced toxicities in patients with renal cell carcinoma
|
Kato, Hiroshi
|
|
2016
|
78 |
4 |
p. 855-862
|
artikel
|
| 6 |
Discovery of LW6 as a new potent inhibitor of breast cancer resistance protein
|
Song, Jae Guen
|
|
2016
|
78 |
4 |
p. 735-744
|
artikel
|
| 7 |
Efficacy and safety of irinotecan monotherapy as third-line treatment for advanced gastric cancer
|
Kawakami, Takeshi
|
|
2016
|
78 |
4 |
p. 809-814
|
artikel
|
| 8 |
Feasibility of dose-dense paclitaxel/carboplatin therapy in elderly patients with ovarian, fallopian tube, or peritoneal cancer
|
Bun, Seiko
|
|
2016
|
78 |
4 |
p. 745-752
|
artikel
|
| 9 |
Impact of metronomic neoadjuvant chemotherapy on early tongue cancer
|
Kina, Shinichiro
|
|
2016
|
78 |
4 |
p. 833-840
|
artikel
|
| 10 |
Impact of treatment duration of neoadjuvant FIRINOX in patients with borderline resectable pancreatic cancer: a pilot trial
|
Okada, Ken-ichi
|
|
2016
|
78 |
4 |
p. 719-726
|
artikel
|
| 11 |
Intestinal permeability to iohexol as an in vivo marker of chemotherapy-induced gastrointestinal toxicity in Sprague–Dawley rats
|
Forsgård, Richard A.
|
|
2016
|
78 |
4 |
p. 863-874
|
artikel
|
| 12 |
Lack of pharmacokinetic drug–drug interaction between ramucirumab and irinotecan in patients with advanced solid tumors
|
Wang, Ding
|
|
2016
|
78 |
4 |
p. 727-733
|
artikel
|
| 13 |
Mitochondria: Inadvertent targets in chemotherapy-induced skeletal muscle toxicity and wasting?
|
Sorensen, James C.
|
|
2016
|
78 |
4 |
p. 673-683
|
artikel
|
| 14 |
Olaparib does not cause clinically relevant QT/QTc interval prolongation in patients with advanced solid tumours: results from two phase I studies
|
Swaisland, Helen
|
|
2016
|
78 |
4 |
p. 775-784
|
artikel
|
| 15 |
Patients homozygous for DPYD c.1129-5923C>G/haplotype B3 have partial DPD deficiency and require a dose reduction when treated with fluoropyrimidines
|
Meulendijks, Didier
|
|
2016
|
78 |
4 |
p. 875-880
|
artikel
|
| 16 |
Pharmacokinetics and pharmacogenetics of 13-cis retinoic acid in Indian high-risk neuroblastoma patients
|
Gota, Vikram
|
|
2016
|
78 |
4 |
p. 763-768
|
artikel
|
| 17 |
Phase II trial of neoadjuvant letrozole and lapatinib in Asian postmenopausal women with estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2)-positive breast cancer [Neo-ALL-IN]: Highlighting the TILs, ER expressional change after neoadjuvant treatment, and FES-PET as potential significant biomarkers
|
Park, Ji Hyun
|
|
2016
|
78 |
4 |
p. 685-695
|
artikel
|
| 18 |
Phase 1 study of the anti-vascular endothelial growth factor receptor 3 monoclonal antibody LY3022856/IMC-3C5 in patients with advanced and refractory solid tumors and advanced colorectal cancer
|
Saif, Muhammad Wasif
|
|
2016
|
78 |
4 |
p. 815-824
|
artikel
|
| 19 |
Prognostic factors from a randomized phase III trial of paclitaxel and carboplatin versus paclitaxel and cisplatin in metastatic or recurrent cervical cancer: Japan Clinical Oncology Group (JCOG) trial: JCOG0505-S1
|
Nishio, Shin
|
|
2016
|
78 |
4 |
p. 785-790
|
artikel
|
| 20 |
Radioimmunotherapy with 131I-rituximab as consolidation therapy for patients with diffuse large B-cell lymphoma
|
Shin, Dong-Yeop
|
|
2016
|
78 |
4 |
p. 825-831
|
artikel
|
| 21 |
Silencing of fused toes homolog enhances cisplatin sensitivity in cervical cancer cells by inhibiting epidermal growth factor receptor-mediated repair of DNA damage
|
Subramanian, Prabakaran D.
|
|
2016
|
78 |
4 |
p. 753-762
|
artikel
|
| 22 |
Sunitinib DDI with paracetamol, diclofenac, mefenamic acid and ibuprofen shows sex-divergent effects on the tissue uptake and distribution pattern of sunitinib in mice
|
Tan, Siok Yean
|
|
2016
|
78 |
4 |
p. 709-718
|
artikel
|
| 23 |
The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy
|
Ahlmann, Martina
|
|
2016
|
78 |
4 |
p. 661-671
|
artikel
|
| 24 |
The metronomic therapy with prednisone, etoposide, and cyclophosphamide reduces the serum levels of VEGF and circulating endothelial cells and improves response rates and progression-free survival in patients with relapsed or refractory non-Hodgkin’s lymphoma
|
Zeng, Jiangzheng
|
|
2016
|
78 |
4 |
p. 801-808
|
artikel
|
| 25 |
Venetoclax does not prolong the QT interval in patients with hematological malignancies: an exposure–response analysis
|
Freise, Kevin J.
|
|
2016
|
78 |
4 |
p. 847-853
|
artikel
|
Tijdschrift beschrijving